​

Kura Oncology (KURA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

KURA Stock Forecast

Kura Oncology (KURA) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $20.75, with a high of $32.00 and a low of $11.00. This represents a 87.95% increase from the last price of $11.04.

$5 $11 $17 $23 $29 $35 High: $32 Avg: $20.75 Low: $11 Last Closed Price: $11.04

KURA Stock Rating

Kura Oncology stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (86.67%), 2 Hold (13.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 15 0 2 13 Strong Sell Sell Hold Buy Strong Buy

KURA Price Target Upside V Benchmarks

TypeNameUpside
StockKura Oncology87.95%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$12.50
Last Closing Price$11.04$11.04$11.04
Upside/Downside--13.22%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 253102--15
Sep, 253101--14
Aug, 253102--15
Jul, 253102--15
Jun, 253102--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2025UBS$14.00$7.7081.82%26.81%
Nov 22, 2024Bradley CaninoStifel Nicolaus$11.00$10.801.85%-0.36%
Oct 24, 2024David DaiUBS$27.00$17.0258.64%144.57%
Oct 14, 2024Bradley CaninoStifel Nicolaus$19.00$18.582.26%72.10%
Jun 25, 2024Joseph PantginisH.C. Wainwright$32.00$21.0851.80%189.86%
May 23, 2024Bradley CaninoStifel Nicolaus$28.00$21.4330.66%153.62%
Dec 22, 2023Mara GoldsteinMizuho Securities$26.00$13.8188.27%135.51%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 20, 2025H.C. WainwrightBuyBuyhold
Sep 04, 2025GuggenheimNeutralinitialise
Nov 18, 2024H.C. WainwrightBuyBuyhold
Oct 24, 2024UBSBuyinitialise
Jun 25, 2024H.C. WainwrightBuyBuyhold
Feb 25, 2022Credit SuisseOutperformOutperformhold
Feb 25, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.08$-2.02----
Avg Forecast$-2.08$-2.39$-1.96$-1.86$-1.30$-0.30
High Forecast$-2.01$-2.14$0.71$0.97$3.14$0.08
Low Forecast$-2.20$-2.50$-3.24$-3.70$-3.91$-0.86
Surprise %--15.48%----

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$53.88M----
Avg Forecast-$7.19M$67.41M$145.46M$273.85M$488.33M
High Forecast-$12.51M$163.54M$147.09M$281.32M$1.18B
Low Forecast-$1.04M$1.48M$143.82M$266.37M$10.75M
Surprise %-649.18%----

Net Income Forecast

$-300M $-190M $-80M $30M $140M $250M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-152.63M$-173.98M----
Avg Forecast$-152.63M$-170.01M$-176.77M$-166.69M$-124.39M$-22.01M
High Forecast$-147.21M$-156.76M$52.31M$71.08M$230.23M$5.97M
Low Forecast$-161.06M$-183.25M$-237.62M$-270.84M$-286.33M$-62.80M
Surprise %-2.34%----

KURA Forecast FAQ

Is Kura Oncology stock a buy?

Kura Oncology stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Kura Oncology is a favorable investment for most analysts.

What is Kura Oncology's price target?

Kura Oncology's price target, set by 15 Wall Street analysts, averages $20.75 over the next 12 months. The price target range spans from $11 at the low end to $32 at the high end, suggesting a potential 87.95% change from the previous closing price of $11.04.

How does Kura Oncology stock forecast compare to its benchmarks?

Kura Oncology's stock forecast shows a 87.95% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Kura Oncology over the past three months?

  • October 2025: 20.00% Strong Buy, 66.67% Buy, 13.33% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 21.43% Strong Buy, 71.43% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 20.00% Strong Buy, 66.67% Buy, 13.33% Hold, 0% Sell, 0% Strong Sell.

What is Kura Oncology’s EPS forecast?

Kura Oncology's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.96, marking a -2.97% decrease from the reported $-2.02 in 2024. Estimates for the following years are $-1.86 in 2026, $-1.3 in 2027, and $-0.3 in 2028.

What is Kura Oncology’s revenue forecast?

Kura Oncology's average annual revenue forecast for its fiscal year ending in December 2025 is $67.41M, reflecting a 25.11% increase from the reported $53.88M in 2024. The forecast for 2026 is $145.46M, followed by $273.85M for 2027, and $488.33M for 2028.

What is Kura Oncology’s net income forecast?

Kura Oncology's net income forecast for the fiscal year ending in December 2025 stands at $-177M, representing an 1.60% increase from the reported $-174M in 2024. Projections indicate $-167M in 2026, $-124M in 2027, and $-22.006M in 2028.